300 related articles for article (PubMed ID: 19388531)
1. [Serum activity of chitotriosidase, lysozyme and cathepsin H in patients with lung cancer and patients with inflammatory exudate (preliminary report)].
Gołab K; Passowicz-Muszyńska E; Jankowska R; Warwas M
Pol Merkur Lekarski; 2009 Mar; 26(153):194-7. PubMed ID: 19388531
[TBL] [Abstract][Full Text] [Related]
2. Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.
Schweiger A; Staib A; Werle B; Krasovec M; Lah TT; Ebert W; Turk V; Kos J
Br J Cancer; 2000 Feb; 82(4):782-8. PubMed ID: 10732746
[TBL] [Abstract][Full Text] [Related]
3. Levels of cathepsins S and H in pleural fluids of inflammatory and neoplastic origin.
Bunatova K; Obermajer N; Kotyza J; Pesek M; Kos J
Int J Biol Markers; 2009; 24(1):47-51. PubMed ID: 19404922
[TBL] [Abstract][Full Text] [Related]
4. Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis.
Bargagli E; Margollicci M; Nikiforakis N; Luddi A; Perrone A; Grosso S; Rottoli P
Respiration; 2007; 74(5):548-52. PubMed ID: 17347558
[TBL] [Abstract][Full Text] [Related]
5. Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardiovascular events independently of C-reactive protein.
Artieda M; Cenarro A; Gañán A; Lukic A; Moreno E; Puzo J; Pocoví M; Civeira F
Cardiology; 2007; 108(4):297-306. PubMed ID: 17290100
[TBL] [Abstract][Full Text] [Related]
6. Pleural fluid lysozyme in human disease.
Klockars M; Pettersson T; Riska H; Hellström PE; Norhagen A
Arch Intern Med; 1979 Jan; 139(1):73-7. PubMed ID: 760686
[TBL] [Abstract][Full Text] [Related]
7. [Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer].
Szajda SD; Darewicz B; Kudelski J; Chlabicz M; Domel T; Chabielska E; Skrzydlewski Z
Pol Merkur Lekarski; 2005 Jun; 18(108):651-3. PubMed ID: 16124376
[TBL] [Abstract][Full Text] [Related]
8. [Significance of detecting E-selectin of serum and pleural effusion in differentiating benign and malignant diseases].
Liu G; Li C; Zhong X
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):556-8. PubMed ID: 11360510
[TBL] [Abstract][Full Text] [Related]
9. Human chitotriosidase: a potential new marker of sarcoidosis severity.
Bargagli E; Maggiorelli C; Rottoli P
Respiration; 2008; 76(2):234-8. PubMed ID: 18487875
[TBL] [Abstract][Full Text] [Related]
10. Chitotriosidase activity in patients with interstitial lung diseases.
Bargagli E; Margollicci M; Luddi A; Nikiforakis N; Perari MG; Grosso S; Perrone A; Rottoli P
Respir Med; 2007 Oct; 101(10):2176-81. PubMed ID: 17631992
[TBL] [Abstract][Full Text] [Related]
11. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK
Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157
[TBL] [Abstract][Full Text] [Related]
12. Chitotriosidase activity in sarcoidosis and some other pulmonary diseases.
Tercelj M; Salobir B; Simcic S; Wraber B; Zupancic M; Rylander R
Scand J Clin Lab Invest; 2009; 69(5):575-8. PubMed ID: 19347743
[TBL] [Abstract][Full Text] [Related]
13. Serum chitotriosidase activity is increased in subjects with atherosclerosis disease.
Artieda M; Cenarro A; Gañán A; Jericó I; Gonzalvo C; Casado JM; Vitoria I; Puzo J; Pocoví M; Civeira F
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1645-52. PubMed ID: 12893688
[TBL] [Abstract][Full Text] [Related]
14. [Plasma chitotriosidase activity in Argentinian patients with Gaucher disease, various lysosomal diseases and other inherited metabolic disorders].
Dodelson de Kremer R; Paschini de Capra A; Angaroni CJ; Giner de Ayala A
Medicina (B Aires); 1997; 57(6):677-84. PubMed ID: 9674188
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic efficiency of serum lipid-bound sialic acid level in malignant pleural effusions].
Bektemür G; Ozer F; Kanat F; Imecik O
Tuberk Toraks; 2003; 51(3):265-70. PubMed ID: 15143404
[TBL] [Abstract][Full Text] [Related]
16. [Cysteine cathepsins secreted into the blood as markers of tumor growth].
Zhloba AA; Dunaevskiĭ VA
Vopr Onkol; 1996; 42(1):70-6. PubMed ID: 8686249
[TBL] [Abstract][Full Text] [Related]
17. Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis.
Boot RG; Hollak CE; Verhoek M; Alberts C; Jonkers RE; Aerts JM
Clin Chim Acta; 2010 Jan; 411(1-2):31-6. PubMed ID: 19808030
[TBL] [Abstract][Full Text] [Related]
18. Serum chitotriosidase activity and Wegener's granulomatosis.
Koening CL; Gota CE; Langford CA; Hoffman GS; Natowicz MR
Clin Biochem; 2010 Mar; 43(4-5):512-4. PubMed ID: 19958755
[TBL] [Abstract][Full Text] [Related]
19. Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum.
Rucińska M; Furman M; Skrzydlewski Z; Zaremba E
Acta Biochim Pol; 1997; 44(1):109-12. PubMed ID: 9241361
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of the activity of plasminogen activators in the differential diagnosis of pleural effusion].
Sil'nichenko OV; Beloglazov VA; Bratchik AM; Zorin VN
Klin Med (Mosk); 1991 Dec; 69(12):46-8. PubMed ID: 1787678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
